Molecular frequency of Coxiella burnetii, Tropheryma whipplei, Brucella, and Bartonella in heart valve tissues from patients with infective endocarditis: A cross-sectional study from Tehran, Iran Authors: Arezoo Dehghan, Mohammad Hossein Ahmadi, Saber Esmaeili, Mohammad Ali Boroumand, Mahshid Hesami Published: 2026 ABSTRACT BackgroundInfective endocarditis (IE) is a life-threatening condition caused by diverse microbial agents and remains a major diagnostic and therapeutic challenge, particularly in cases of blood culture–negative IE (BCN-IE).MethodsIn this cross-sectional study, 405 formalin-fixed paraffin-embedded heart valve tissue samples from 232 patients with pathologically and clinically confirmed IE who underwent valve replacement were collected between March 2021 and March 2025 from two tertiary referral hospitals in Tehran, Iran. Following DNA extraction, Coxiella burnetii, Brucella spp., and Bartonella spp. were detected using TaqMan real-time PCR, while Tropheryma whipplei was identified by SYBR Green real-time PCR. Species-level identification of Brucella and Bartonella in positive samples was performed using conventional and multiplex real-time PCR.ResultsOverall, C. burnetii, Brucella spp., Bartonella spp., and T. whipplei were detected in 6.9%, 8.6%, 5.6%, and 3.0% of patients, respectively. The study population comprised 156 males (67.2%) and 76 females (32.8%), with a mean age of 47 years. The aortic (40.3%) and mitral (39.1%) valves were the most frequently involved sites. Bartonella quintana, Brucella melitensis, and Brucella abortus were identified among positive samples. Dyspnea was significantly associated with C. burnetii (P = 0.02), Bartonella (P = 0.04), and Brucella infections (P = 0.009), while fever (P = 0.03) and sweating (P = 0.001) were significantly associated with Brucella infection.ConclusionsFastidious and intracellular pathogens are important but overlooked causes of BCN-IE in Iran. Molecular analysis of heart valve tissues represents a valuable diagnostic strategy and supports the need for improved surveillance, prevention, and targeted management of zoonotic and fastidious agents in IE. Introduction Infective endocarditis (IE) is a serious and potentially fatal condition characterized by infection and inflammation of the endocardium and heart valves [1,2]. Endocarditis as a rare but high mortality disease is generally classified as infectious and non-infectious (NIE) [3]. In approximately 80% of IE cases, the causative pathogens are conventional bacteria, including Streptococcus, Staphylococcus, and Enterococcus species. However, nearly 20% of cases are attributed to fastidious or atypical microorganisms such as members of the HACEK group, Coxiella burnetii, Bartonella spp., Brucella spp., Tropheryma whipplei, and Legionella spp., which frequently result in blood culture–negative infective endocarditis (BCN-IE) [1,4]. The pathogenesis of IE begins with microbial adhesion to damaged endothelial surfaces, followed by bacterial colonization, activation of inflammatory and cytokine pathways, increased fibronectin deposition, and subsequent formation of vegetative thrombotic lesions. Risk factors such as prior cardiac surgery, prosthetic valves, hemodialysis, injection drug use, and intravascular catheterization significantly increase susceptibility to the infection [4,5]. Despite advances in antimicrobial therapy and diagnostic modalities, the global burden of IE has risen over recent decades, with increasing incidence and mortality rates, particularly among older male populations [4,6]. According to the modified Duke criteria and European Society of Cardiology (ESC) guidelines, microbiological evidence and cardiac imaging remain central to the diagnosis of IE. However, conventional blood cultures fail to identify the causative agent in up to 20% of cases, underscoring the importance of serological and nucleic acid–based diagnostic approaches as rapid and accurate methods, particularly for fastidious intracellular pathogens [[6], [7], [8]]. Coxiella burnetii, an obligate intracellular Gram-negative bacterium and the causative agent of Q fever, represents the most frequent etiological agent of BCN-IE worldwide [9,10]. Bartonella spp., particularly B. quintana and B. henselae, account for a substantial proportion of BCN-IE through biofilm-associated valvular infection [11]. Brucella spp., zoonotic facultative intracellular coccobacilli, represent the leading cause of mortality in brucellosis and are responsible for a small but clinically significant fraction of BCN-IE cases [12]. Tropheryma whipplei, the causative agent of Whipple's disease, is an emerging pathogen in culture-negative endocarditis, often diagnosed only through molecular analysis of excised heart valve tissue [13]. Despite the recognized role of fastidious pathogens in blood culture–negative infective endocarditis, molecular data from Iran remain scarce and largely limited to single-agent studies. This study addresses this gap by providing a comprehensive molecular assessment of C. burnetii, T. whipplei, Brucella spp., and Bartonella spp. in heart valve tissues from patients with confirmed infective endocarditis in major referral centers in Iran. By simultaneously targeting multiple key etiological agents, this work offers novel epidemiological insights and underscores the clinical value of molecular diagnostics for improving the etiological identification and management of infective endocarditis in endemic settings. Material and methods Study design and sample collection This cross-sectional study included 405 formalin-fixed paraffin-embedded (FFPE) heart valve tissue blocks obtained from 232 patients with clinically and pathologically confirmed infective endocarditis who underwent valve replacement surgery. Samples were collected between March 2021 and March 2025 from two tertiary cardiac referral centers in Tehran, Iran: Shahid Rajaee Heart Center and Tehran Heart Center. Clinical and pathological records were reviewed to confirm the diagnosis and eligibility criteria. Selected samples were transferred to the Pasteur Institute of Iran (National Reference Laboratory) for molecular analysis. Sectioning and deparaffinization of FFPE tissues Paraffin blocks were sectioned into 5-μm-thick slices using a sterile scalpel blade and transferred into labeled sterile microtubes. Deparaffinization was performed by adding 1200 μL of xylene to each tube, followed by vortexing for 5 min and incubation in a thermomixer at 70 °C for 10 min. Samples were then centrifuged at 13000 rpm for 5 min, and the supernatant was carefully removed. Subsequently, 1200 μL of absolute ethanol was added, vortexed for 1–2 min, and centrifuged at 13000 rpm for 5 min. The ethanol washing step was repeated twice, followed by air-drying of the tissue pellet [[14], [15], [16]]. DNA extraction and quality assessment All tissue samples were homogenized using a TissueLyser (Qiagen, Germany) for 6 min at 30 Hz, before starting the DNA extraction process. Genomic DNA was extracted from deparaffined tissues samples using a commercial DNA Extraction Kit (Viragene Co, Iran), according to the manufacturer's instructionsDNA concentration and purity were assessed using a NanoDrop spectrophotometer (Epoch, BioTek, USA). Samples with A260/A280 ratios between 1.8 and 2.0 and A260/A230 ratios between 2.0 and 2.5 were considered suitable for downstream molecular analyses. Molecular detection of Coxiella burnetii All extracted DNA samples were screened for C. burnetii by TaqMan real-time PCR targeting the IS1111 gene (Table 1). Amplification was performed using the Rotor-Gene 6000 real-time PCR system (Corbett, Victoria, Australia) with the following cycling conditions: initial activation at 95 °C for 3 min, followed by 45 cycles of denaturation at 95 °C for 10 s and annealing/extension at 60 °C for 30 s. Data were analyzed using Rotor-Gene® Q software version 2.3.5 (QIAGEN).Table 1Primer and probe sequences used in the molecular methods.Table 1PathogenGeneF-primer (5′-3′)R-primer (5′-3′)Product Size (bp)ReferenceCoxiella burnetiiIS1111AAAACGGATAAAAAGAGTCTGTGGTTCCACACAAGCGCGATTCAT70[17,18]Probe6-FAM-AAAGCACTCATTGAGCGCCGCG-TAMRABrucellaIS711GCTTGAAGCTTGCGGACAGTGGCCTACCGCTGCGAAT63[18,19]ProbeFAM-AAGCCAACACCCGGCCATTATGGT-TAMRABartonella16s-23srRNAGGGGAAGGTTTTCCGGTTTATCGAGGACTTGAACCTCCGACC92[20]Probe6_FAM_GGAGGGCTTGTAGCTCAGYTGGTTAGAGCG-TAMRABartonella16srRNATTAGAGTGAGCGGCAAACTACCGTCATTATCTTCACCG356[21]Tropheryma whippleiTWSPAGAGAGATGGGGTGCAGGACAGCCTTTGCCAGACAGACAC210[22]Brucella melitensisBMEII0466TCGCATCGGCAGTTTCAACCAGCTTTTGGCCTTTTCC67[19,23]ProbeTEX-CCTCGGCATGGCCCGCAA-BHQBrucella abortusBruAb2_0168GCACACTCACCTTCCACAACAACCCCGTTCTGCACCAGACT81[19,23]ProbeHEX-TGGAACGACCTTTGCAGGCGAGATC-BHQ−1Brucella suisBR0952CCTGCAAAAAGCAGGAACCACCTCCGCCAGTCGTGAAA965[19]Brucella canisBMEII0635-0636AAAATGCGGATCGGCCTTTCCCGGCGCATTGCT749[19] Table 1Primer and probe sequences used in the molecular methods.Table 1PathogenGeneF-primer (5′-3′)R-primer (5′-3′)Product Size (bp)ReferenceCoxiella burnetiiIS1111AAAACGGATAAAAAGAGTCTGTGGTTCCACACAAGCGCGATTCAT70[17,18]Probe6-FAM-AAAGCACTCATTGAGCGCCGCG-TAMRABrucellaIS711GCTTGAAGCTTGCGGACAGTGGCCTACCGCTGCGAAT63[18,19]ProbeFAM-AAGCCAACACCCGGCCATTATGGT-TAMRABartonella16s-23srRNAGGGGAAGGTTTTCCGGTTTATCGAGGACTTGAACCTCCGACC92[20]Probe6_FAM_GGAGGGCTTGTAGCTCAGYTGGTTAGAGCG-TAMRABartonella16srRNATTAGAGTGAGCGGCAAACTACCGTCATTATCTTCACCG356[21]Tropheryma whippleiTWSPAGAGAGATGGGGTGCAGGACAGCCTTTGCCAGACAGACAC210[22]Brucella melitensisBMEII0466TCGCATCGGCAGTTTCAACCAGCTTTTGGCCTTTTCC67[19,23]ProbeTEX-CCTCGGCATGGCCCGCAA-BHQBrucella abortusBruAb2_0168GCACACTCACCTTCCACAACAACCCCGTTCTGCACCAGACT81[19,23]ProbeHEX-TGGAACGACCTTTGCAGGCGAGATC-BHQ−1Brucella suisBR0952CCTGCAAAAAGCAGGAACCACCTCCGCCAGTCGTGAAA965[19]Brucella canisBMEII0635-0636AAAATGCGGATCGGCCTTTCCCGGCGCATTGCT749[19] Primer and probe sequences used in the molecular methods. Molecular identification of Bartonella spp. Detection of Bartonella spp. was carried out using real-time PCR targeting the 16S–23S rRNA intergenic spacer region (Table 1). The amplification protocol consisted of an initial activation at 95 °C for 3 min, followed by 45 cycles of 95 °C for 10 s and 60 °C for 30 s, using the Rotor-Gene 6000 system. All Bartonella-positive samples were further analyzed by conventional PCR targeting the 16S rRNA gene for identification of Bartonella species (Table 1). PCR products were visualized on a 1.5% agarose gel, and samples yielding specific bands were subjected to Sanger sequencing. Obtained sequences were analyzed using BLAST against the NCBI GenBank database (https://blast.ncbi.nlm.nih.gov/Blast.cgi) and MEGA11 software, and phylogenetic analysis was performed. Molecular identification of Brucella spp. TaqMan real-time PCR targeting the IS711 gene was used for the detection of Brucella spp. in all DNA samples (Table 1). The amplification program consisted of an initial activation at 95 °C for 3 min, followed by 45 cycles of 95 °C for 10 s and 60 °C for 30 s, using the Rotor-Gene 6000 system. Species-level identification of Brucella-positive samples was performed using multiplex real-time PCR targeting specific genes of Brucella melitensis and Brucella abortus. Additionally, conventional PCR assays were conducted to detect Brucella suis and Brucella canis (Table 1), with amplification products analyzed by electrophoresis on 2% agarose gels [19]. Molecular detection of Tropheryma whipplei Detection of T. whipplei was performed using SYBR Green real-time PCR targeting the wisp gene (Table 1). Amplification conditions included an initial activation at 95 °C for 15 min, followed by 45 cycles of denaturation at 95 °C for 15 s, annealing at 59 °C for 30 s, and extension at 72 °C for 30 s. After amplification, the melting protocol was followed by raising the temperature slowly from 65 to 97 °C to differentiate the specific and non-specific amplified amplicons. The samples with suitable amplification and melting (80 ± 0.5 °C) curves were considered positive for T. whipplei. Statistical analysis Statistical analyses were performed using SPSS software version 27.0 (IBM Corp., Armonk, NY, USA). Descriptive statistics were used to summarize demographic, clinical, and laboratory data. Categorical variables were expressed as frequencies and percentages, while continuous variables were reported as mean ± standard deviation or median with interquartile range, as appropriate. The frequency of each detected pathogen was calculated with corresponding proportions. Comparisons between categorical variables were conducted using the chi-square test or Fisher's exact test, when applicable. A two-tailed P value of <0.05 was considered statistically significant. Results Demographic, clinical, and laboratory characteristics A total of 405 formalin-fixed paraffin-embedded heart valve tissue samples (131 patients with 1 block, 64 with 2 blocks, 23 with 3 blocks, 18 with 4 blocks and 1 patient with 5 blocks) obtained from 232 patients with infective endocarditis were included in this study. The study population comprised 156 males (67.2%) and 76 females (32.8%), with a mean age of 47.3 ± 20 years. Patients originated from 25 provinces across Iran, with the highest number of cases reported from Tehran (48.0%, n = 110), followed by Gilan (8.3%, n = 19) and Alborz (7.8%, n = 18) (Table 2, Table 3).Table 2Summary results of frequency analyses.Table 2CharacteristicsAll Patient of IE (%)C. burnetii positive (%)Bartonella positive (%)Brucella positive (%)T. whipplei positive (%)Female76 (33)6 (37.5)2 (15.4)9 (45)3 (43)Male156 (67)10 (62.5)11 (84.6)11 (55)4 (57)Age (mean)47.344494551Village12 (5)3 (18.8)01 (5)0Urban220 (95)13 (81.2)13 (100)19 (95)7 (100)BCN159 (68.5)13 (81.2)9 (69)19 (95)7 (100)TCN124 (53)7 (43.8)7 (53.8)17 (85)6 (85.7)Death43 (18.5)5 (31.2)3 (23)4 (20)0Mitral valve99 (38.8)6 (33.3)8 (53.34)5 (25)1 (12.5)Aortic valve102 (40)11 (61.2)5 (33.34)11 (55)6 (75)Tricuspid23 (9)1 (5.55)1 (6.66)00Pulmonary8 (3.2)01 (6.66)1 (5)1 (12.5)Pericardium wall23 (9)003 (15)0Total Number of patients2321613207Total Number of tissues2551815208IE: infective endocarditis; BCN: Blood culture negative; TCN: tissue culture negative.Table 3Province distribution of patients.Table 3ProvinceTotal (%)C. burnetiiPositive (%)BartonellaPositive (%)BrucellaPositive (%)T. whippleiPositive (%)Ardabil5 (2.1)0000East Azarbaijan1 (0.43)0000West Azarbaijan2 (0.86)001 (5)0Tehran110 (47.4)7 (43.8)8 (61.5)10 (50)4 (57)Khorasan Razavi1 (0.43)0000Khozestan9 (3.87)0000Zanjan2 (0.86)0001 (14)Semnan2 (0.86)0000Sistan and Baluchestan4 (1.72)1 (6.3)000Chaharmahal and Bakhtiari1 (0.43)0000Qazvin3 (1.3)1 (6.3)02 (10)0Qom7 (3)01 (7.7)00Isfahan4 (1.72)001 (5)0Alborz18 (7.75)1 (6.3)1 (7.7)1 (5)0Kurdistan3 (1.3)0000Kerman3 (1.3)1 (6.3)01 (5)0Kermanshah4 (1.72)1 (6.3)01 (5)0Golestan5 (2.1)01 (7.7)00Gilan19 (8.2)2 (12.5)1 (7.7)1 (5)1 (14)Lorestan6 (2.6)1 (6.3)1 (7.7)00Mazandaran9 (3.87)001 (5)1 (14)Markazi3 (1.3)001 (5)0Hormozgan3 (1.3)1 (6.3)000Hamedan4 (1.72)0000unknown3 (1.3)0000Other nationalities (Afghanistan)1 (0.43)0000Total2321613207 Table 2Summary results of frequency analyses.Table 2CharacteristicsAll Patient of IE (%)C. burnetii positive (%)Bartonella positive (%)Brucella positive (%)T. whipplei positive (%)Female76 (33)6 (37.5)2 (15.4)9 (45)3 (43)Male156 (67)10 (62.5)11 (84.6)11 (55)4 (57)Age (mean)47.344494551Village12 (5)3 (18.8)01 (5)0Urban220 (95)13 (81.2)13 (100)19 (95)7 (100)BCN159 (68.5)13 (81.2)9 (69)19 (95)7 (100)TCN124 (53)7 (43.8)7 (53.8)17 (85)6 (85.7)Death43 (18.5)5 (31.2)3 (23)4 (20)0Mitral valve99 (38.8)6 (33.3)8 (53.34)5 (25)1 (12.5)Aortic valve102 (40)11 (61.2)5 (33.34)11 (55)6 (75)Tricuspid23 (9)1 (5.55)1 (6.66)00Pulmonary8 (3.2)01 (6.66)1 (5)1 (12.5)Pericardium wall23 (9)003 (15)0Total Number of patients2321613207Total Number of tissues2551815208IE: infective endocarditis; BCN: Blood culture negative; TCN: tissue culture negative. Summary results of frequency analyses. IE: infective endocarditis; BCN: Blood culture negative; TCN: tissue culture negative. Table 3Province distribution of patients.Table 3ProvinceTotal (%)C. burnetiiPositive (%)BartonellaPositive (%)BrucellaPositive (%)T. whippleiPositive (%)Ardabil5 (2.1)0000East Azarbaijan1 (0.43)0000West Azarbaijan2 (0.86)001 (5)0Tehran110 (47.4)7 (43.8)8 (61.5)10 (50)4 (57)Khorasan Razavi1 (0.43)0000Khozestan9 (3.87)0000Zanjan2 (0.86)0001 (14)Semnan2 (0.86)0000Sistan and Baluchestan4 (1.72)1 (6.3)000Chaharmahal and Bakhtiari1 (0.43)0000Qazvin3 (1.3)1 (6.3)02 (10)0Qom7 (3)01 (7.7)00Isfahan4 (1.72)001 (5)0Alborz18 (7.75)1 (6.3)1 (7.7)1 (5)0Kurdistan3 (1.3)0000Kerman3 (1.3)1 (6.3)01 (5)0Kermanshah4 (1.72)1 (6.3)01 (5)0Golestan5 (2.1)01 (7.7)00Gilan19 (8.2)2 (12.5)1 (7.7)1 (5)1 (14)Lorestan6 (2.6)1 (6.3)1 (7.7)00Mazandaran9 (3.87)001 (5)1 (14)Markazi3 (1.3)001 (5)0Hormozgan3 (1.3)1 (6.3)000Hamedan4 (1.72)0000unknown3 (1.3)0000Other nationalities (Afghanistan)1 (0.43)0000Total2321613207 Province distribution of patients. Blood and tissue cultures were performed for 209 and 162 samples, respectively. Positive results were obtained in 50 blood cultures and 38 tissue cultures, while the remaining cultures were negative. The most frequently isolated organisms from culture-positive samples were Streptococcus spp., Staphylococcus spp., Enterococcus spp., and Pseudomonas aeruginosa. Among the 232 patients, the number of tissue samples obtained from the aortic, mitral, tricuspid, and pulmonary valves, as well as from pericardial tissue, was 102, 99, 23, 8, and 23, respectively. Regarding the anatomical distribution of samples, 40.0% originated from the aortic valve, 38.8% from the mitral valve, 9.0% from the tricuspid valve, 3.2% from the pulmonary valve, and 9.0% from pericardium tissue, among a total of 255 tissue samples obtained from 232 patients. Fever (≥38 °C) was documented in 16.0% of patients. Diabetes mellitus, hypertension, and substance use were present in 8.0%, 15.0%, and 9.0% of cases, respectively. The most common presenting symptoms included dyspnea (42.2%), chest pain (16.5%), fever (16%), and unintentional weight loss. Overall, 43 patients (18.5%) died due to cardiac complications (Table 4).Table 4Analysis of factors related to C. burnetii, T. whipplei, Brucella and Bartonella in patients with infective endocarditis from 2021 to 2025.Table 4CharacteristicsC. burnetii PositiveBartonella spp. PositiveBrucella spp. PositiveT. whipplei PositiveCount (%)P valueOR (CI)Count (%)P valueOR (CI)Count (%)P valueOR (CI)CountP valueOR (CI)GenderFemale6 (37.5)0.60.8 (0.28-2.3)2 (15.4)0.22.8 (0.6-13)9 (45)0.20.56 (0.2-1.4)3 (42.9)0.680.64 (0.14-2.9)Male10 (62.5)11 (84.6)11 (55)4 (57.1)DeathNo11 (68.8)0.182 (0.7-6.510 (76.9)0.71.3 (0.35-5)16 (80)0.71.1 (0.34-3.4)6 (85.7)0.350.96 (0.93-0.99)Yes5 (31.3)3 (23.1)4 (20)1 (14.3)SmokingNegative15 (93.8)0.990.65 (0.08-5)10 (76.9)0.13.3 (0.8-13)20 (100)0.220.9 (0.86-0.94)6 (85.7)0.491.7 (0.19-14.9)Positive1 (6.3)3 (23.1)01 (14.3)DiabeticNegative15 (93.8)0.990.7 (0.09-5.8)10 (76.9)0.083.8 (0.95-15)20 (100)0.380.9 (0.86-0.46 (85.7)0.451.9 (0.2-16)Positive1 (6.3)3 (23.1)01 (14.3)High blood pressureNegative14 (87.5)0.990.8 (0.18-3.8)10 (76.9)0.41.8 (0.47-7)19 (95)0.30.28 (0.037-2.2)5 (71.4)0.990.97 (0.11-8.3)Positive2 (12.5)3 (23.1)1 (5)2 (28.6)DyspneaNegative5 (31.3)0.023.2 (1-9.7)4 (30.8)0.043 (0.98-11)6 (30)0.0093.5 (1.3-9.6)3 (42.9)0.991 (0.22-4.6)Positive11 (68.8)9 (69.2)14 (70)4 (57.1)Chest painNegative15 (93.8)0.480.3 (0.04-2.5)12 (92.3)0.70.4 (0.05-3.2)18 (90)0.540.54 (0.12-2.44)3 (42.9)0.17.4 (1.6-34.9)Positive1 (6.3)1 (7.7)2 (10)4 (57.1)FeverNegative12 (75)0.291.8 (0.56-6)9 (69.2)0.132.5 (0.7-8.6)11 (55)0.0015.3 (2-14)7 (100)0.60.96 (0.94-0.99)Positive4 (25)4 (30.8)9 (45)0ChillsNegative13 (81.3)0.471.4 (0.4-5.5)9 (69.2)0.083 (0.87-10.5)13 (65)0.14 (1.46-11)7 (100)0.590.96 (0.94-0.99)Positive3 (18.8)4 (30.8)7 (35)0FatigueNegative15 (93.8)0.990.8 (0.097-6)10 (76.9)0.074 (1-16.4)18 (90)0.651.36 (0.3-6.3)5 (71.4)0.095 (0.93-29)Positive1 (6.3)3 (23.1)2 (10)2 (28.6)Weight lossNegative16 (100)0.990.9 (0.8-0.96)13 (100)0.990.94 (0.9-0.97)18 (90)0.272.2 (0.45-11)6 (85.7)0.33.2 (0.35-29)Positive002 (10)1 (14.3)PalpitationNegative15 (93.8)0.581.2 (0.15-10)12 (92.3)0.51.5 (0.18-13)19 (95)0.990.96 (0.11-7.8)7 (100)0.990.96 (0.94-0.99)Positive1 (6.3)1 (7.7)1 (5)0SweatingNegative16 (100)0.990.9 (0.89-0.96)13 (100)0.990.94 (0.91-0.97)17 (85)0.036 (1.4-26)7 (100)0.990.96 (0.94-0.99)Positive003 (15)0CoughNegative15 (93.8)0.51.3 (0.16-11.4)11 (84.6)0.124 (0.8-22)17 (85)0.0584.5 (1-18)7 (100)0.990.96 (0.94-0.99)Positive1 (6.3)2 (15.4)3 (15)0EdemaNegative16 (100)0.990.9 (0.9-0.96)12 (92.3)0.32.9 (0.3-26.5)20 (100)0.990.9 (0.87-0.94)7 (100)0.990.96 (0.94-0.99)Positive01 (7.7)00LocationUrban13 (81.3)0.045 (1.2-22)13 (100)0.990.94 (0.9-0.9719 (95)0.990.96 (0.11-7.8)7 (100)0.990.96 (0.94-0.99)Village3 (18.8)01 (5)0Valve typeAortic11 (61.2)0.052.5 (1-6.7)5 (33.34)0.580.0.73 (0.24-2.2)11 (55)0.151.9 (0.77-4.8)6 (75)0.054.7 (1-24)Mitral6 (33.3)0.620.77 (0.3-2)8 (53.34)0.21.88 (0.65-5.3)5 (25)0.180.5 (0.17-1.4)1 (12.5)0.150.2 (0.026-1.8)Pulmonary0001 (6.66)0.992.4 (0.27-20.6)1 (5)0.481.7 (0.2-14.6)1 (12.5)0.224.9 (0.5-45.4)Tricuspid1 (5.55)0.990.57(0.07-4.5)1 (6.66)0.990.7 (0.09-5.6)000000Pericardium tissue0000003 (15)0.41.9 (0.5-7)000OR: odds ratio; CI: confidence interval. Table 4Analysis of factors related to C. burnetii, T. whipplei, Brucella and Bartonella in patients with infective endocarditis from 2021 to 2025.Table 4CharacteristicsC. burnetii PositiveBartonella spp. PositiveBrucella spp. PositiveT. whipplei PositiveCount (%)P valueOR (CI)Count (%)P valueOR (CI)Count (%)P valueOR (CI)CountP valueOR (CI)GenderFemale6 (37.5)0.60.8 (0.28-2.3)2 (15.4)0.22.8 (0.6-13)9 (45)0.20.56 (0.2-1.4)3 (42.9)0.680.64 (0.14-2.9)Male10 (62.5)11 (84.6)11 (55)4 (57.1)DeathNo11 (68.8)0.182 (0.7-6.510 (76.9)0.71.3 (0.35-5)16 (80)0.71.1 (0.34-3.4)6 (85.7)0.350.96 (0.93-0.99)Yes5 (31.3)3 (23.1)4 (20)1 (14.3)SmokingNegative15 (93.8)0.990.65 (0.08-5)10 (76.9)0.13.3 (0.8-13)20 (100)0.220.9 (0.86-0.94)6 (85.7)0.491.7 (0.19-14.9)Positive1 (6.3)3 (23.1)01 (14.3)DiabeticNegative15 (93.8)0.990.7 (0.09-5.8)10 (76.9)0.083.8 (0.95-15)20 (100)0.380.9 (0.86-0.46 (85.7)0.451.9 (0.2-16)Positive1 (6.3)3 (23.1)01 (14.3)High blood pressureNegative14 (87.5)0.990.8 (0.18-3.8)10 (76.9)0.41.8 (0.47-7)19 (95)0.30.28 (0.037-2.2)5 (71.4)0.990.97 (0.11-8.3)Positive2 (12.5)3 (23.1)1 (5)2 (28.6)DyspneaNegative5 (31.3)0.023.2 (1-9.7)4 (30.8)0.043 (0.98-11)6 (30)0.0093.5 (1.3-9.6)3 (42.9)0.991 (0.22-4.6)Positive11 (68.8)9 (69.2)14 (70)4 (57.1)Chest painNegative15 (93.8)0.480.3 (0.04-2.5)12 (92.3)0.70.4 (0.05-3.2)18 (90)0.540.54 (0.12-2.44)3 (42.9)0.17.4 (1.6-34.9)Positive1 (6.3)1 (7.7)2 (10)4 (57.1)FeverNegative12 (75)0.291.8 (0.56-6)9 (69.2)0.132.5 (0.7-8.6)11 (55)0.0015.3 (2-14)7 (100)0.60.96 (0.94-0.99)Positive4 (25)4 (30.8)9 (45)0ChillsNegative13 (81.3)0.471.4 (0.4-5.5)9 (69.2)0.083 (0.87-10.5)13 (65)0.14 (1.46-11)7 (100)0.590.96 (0.94-0.99)Positive3 (18.8)4 (30.8)7 (35)0FatigueNegative15 (93.8)0.990.8 (0.097-6)10 (76.9)0.074 (1-16.4)18 (90)0.651.36 (0.3-6.3)5 (71.4)0.095 (0.93-29)Positive1 (6.3)3 (23.1)2 (10)2 (28.6)Weight lossNegative16 (100)0.990.9 (0.8-0.96)13 (100)0.990.94 (0.9-0.97)18 (90)0.272.2 (0.45-11)6 (85.7)0.33.2 (0.35-29)Positive002 (10)1 (14.3)PalpitationNegative15 (93.8)0.581.2 (0.15-10)12 (92.3)0.51.5 (0.18-13)19 (95)0.990.96 (0.11-7.8)7 (100)0.990.96 (0.94-0.99)Positive1 (6.3)1 (7.7)1 (5)0SweatingNegative16 (100)0.990.9 (0.89-0.96)13 (100)0.990.94 (0.91-0.97)17 (85)0.036 (1.4-26)7 (100)0.990.96 (0.94-0.99)Positive003 (15)0CoughNegative15 (93.8)0.51.3 (0.16-11.4)11 (84.6)0.124 (0.8-22)17 (85)0.0584.5 (1-18)7 (100)0.990.96 (0.94-0.99)Positive1 (6.3)2 (15.4)3 (15)0EdemaNegative16 (100)0.990.9 (0.9-0.96)12 (92.3)0.32.9 (0.3-26.5)20 (100)0.990.9 (0.87-0.94)7 (100)0.990.96 (0.94-0.99)Positive01 (7.7)00LocationUrban13 (81.3)0.045 (1.2-22)13 (100)0.990.94 (0.9-0.9719 (95)0.990.96 (0.11-7.8)7 (100)0.990.96 (0.94-0.99)Village3 (18.8)01 (5)0Valve typeAortic11 (61.2)0.052.5 (1-6.7)5 (33.34)0.580.0.73 (0.24-2.2)11 (55)0.151.9 (0.77-4.8)6 (75)0.054.7 (1-24)Mitral6 (33.3)0.620.77 (0.3-2)8 (53.34)0.21.88 (0.65-5.3)5 (25)0.180.5 (0.17-1.4)1 (12.5)0.150.2 (0.026-1.8)Pulmonary0001 (6.66)0.992.4 (0.27-20.6)1 (5)0.481.7 (0.2-14.6)1 (12.5)0.224.9 (0.5-45.4)Tricuspid1 (5.55)0.990.57(0.07-4.5)1 (6.66)0.990.7 (0.09-5.6)000000Pericardium tissue0000003 (15)0.41.9 (0.5-7)000OR: odds ratio; CI: confidence interval. Analysis of factors related to C. burnetii, T. whipplei, Brucella and Bartonella in patients with infective endocarditis from 2021 to 2025. OR: odds ratio; CI: confidence interval. Detection of Coxiella burnetii Coxiella burnetii DNA was detected in 16 of 232 patients (6.9%). Of the positive cases, 11 samples were obtained from Shahid Rajaee Heart Center and five from Tehran Heart Center. Most affected patients were male (n = 10), with a mean age of 44 years. Aortic valve involvement was the most frequent finding (61.2%) and was significantly associated with C. burnetii positivity (odds ratio [OR]: 2.5; 95% confidence interval [CI]: 1–6.7; P = 0.05). The majority of positive cases were residents of Tehran Province, and five patients (31.3%) died during hospitalization (Table 5).Table 5Clinical characteristics of patients infected by Coxiella burnetii and Bartonella spp.Table 5Coxiella burnetiiPatients IDValveProvinceGenderBlood GroupAgeDeathSmokingDiabeticHigh Blood PressureDyspneaChest painEdemaFeverChillsFatigueWeight lossPalpitationSweatingCoughLocationE251AorticKarajFemaleO+31YesNoNoNoYesNoNoNoNoYesNoNoNoNoUrbanE323MitralTehranMaleO+12NoNoNoNoNoNoYesYesNoNoNoNoNoUrbanE274TricuspidGilanFemaleAB+57NoNoNoYesNoNoNoNoNoNoNoNoNoVillageE255TricuspidTehranFemaleA+64YesNoNoYesYesNoNoNoNoNoNoNoNoNoUrbanE374TricuspidSistan and BaluchestanFemaleA+19YesNoNoNoYesNoNoYesYesNoNoNoNoNoVillageE325Tricuspid & AorticKermanshahMaleB+36NoNoNoYesNoNoNoNoNoNoNoNoNoUrbanE445TricuspidTehranMaleB+42NoNoNoNoYesNoNoNoNoNoNoNoNoUrbanE287MitralHormozganFemaleA+53NoNoNoNoNoNoNoNoNoNoNoNoNoVillageE262MitralQazvinFemaleA+37NoNoNoYesNoNoYesYesNoNoNoNoNoUrbanE278Mitral & AorticTehranMaleO+56NoNoNoYesNoNoNoNoNoNoNoNoNoUrbanE464AorticTehranMaleA+25YesNoNoYesNoNoNoNoNoNoNoNoNoUrbanE394MitralLorestanMaleA+66YesNoYesYesYesNoNoNoNoNoNoNoNoYesUrbanE451AorticTehranMaleA+71YesNoNoNoYesNoNoNoNoNoNoNoNoNoUrbanE288AorticKermanMaleB+31NoNoNoNoNoNoYesNoNoNoNoNoNoUrbanE254MitralTehranMaleA+62NoNoNoYesNoNoNoNoNoNoYesNoNoUrbanE453AorticGilanMaleB+42NoNoNoNoNoNoNoNoNoNoNoNoNoUrbanBartonella spp.E251AorticKarajFemaleO+31YesNoNoNoYesNoNoNoNoYesNoNoNoNoUrbanE469Aortic & TricuspidTehranMaleA+64NoYesNoYesNoNoNoNoNoNoNoNoNoUrbanE419MitralTehranMaleO+43YesNoNoYesNoNoNoNoNoNoNoNoNoUrbanE313AorticTehranMaleB+63NoYesYesYesNoYesNoNoNoNoNoNoNoUrbanE465MitralTehranMaleO+31YesNoNoYesNoNoYesYesNoNoNoNoYesUrbanE270Mitral & AorticTehranMaleA+56NoNoNoYesNoNoNoNoNoNoNoNoNoUrbanE268MitralTehranMaleO-78YesNoNoNoNoNoNoNoNoNoNoNoNoNoUrbanE395AorticGolestanMaleA+34YesNoNoYesNoNoYesYesNoNoNoNoNoUrbanE394MitralLorestanMaleA+66YesNoYesYesYesNoNoNoNoNoNoNoNoYesUrbanE458MitralGilanMaleB+67NoNoYesNoYesNoNoNoNoNoNoNoNoUrbanE309PulmonaryQomFemaleO+22NoNoNoNoNoNoYesYesYesNoNoNoNoUrbanE254MitralTehranMaleA+62NoNoNoYesNoNoNoNoNoNoYesNoNoUrbanE240MitralTehranMaleB-31NoNoNoNoNoNoYesYesYesNoNoNoNoUrban Table 5Clinical characteristics of patients infected by Coxiella burnetii and Bartonella spp.Table 5Coxiella burnetiiPatients IDValveProvinceGenderBlood GroupAgeDeathSmokingDiabeticHigh Blood PressureDyspneaChest painEdemaFeverChillsFatigueWeight lossPalpitationSweatingCoughLocationE251AorticKarajFemaleO+31YesNoNoNoYesNoNoNoNoYesNoNoNoNoUrbanE323MitralTehranMaleO+12NoNoNoNoNoNoYesYesNoNoNoNoNoUrbanE274TricuspidGilanFemaleAB+57NoNoNoYesNoNoNoNoNoNoNoNoNoVillageE255TricuspidTehranFemaleA+64YesNoNoYesYesNoNoNoNoNoNoNoNoNoUrbanE374TricuspidSistan and BaluchestanFemaleA+19YesNoNoNoYesNoNoYesYesNoNoNoNoNoVillageE325Tricuspid & AorticKermanshahMaleB+36NoNoNoYesNoNoNoNoNoNoNoNoNoUrbanE445TricuspidTehranMaleB+42NoNoNoNoYesNoNoNoNoNoNoNoNoUrbanE287MitralHormozganFemaleA+53NoNoNoNoNoNoNoNoNoNoNoNoNoVillageE262MitralQazvinFemaleA+37NoNoNoYesNoNoYesYesNoNoNoNoNoUrbanE278Mitral & AorticTehranMaleO+56NoNoNoYesNoNoNoNoNoNoNoNoNoUrbanE464AorticTehranMaleA+25YesNoNoYesNoNoNoNoNoNoNoNoNoUrbanE394MitralLorestanMaleA+66YesNoYesYesYesNoNoNoNoNoNoNoNoYesUrbanE451AorticTehranMaleA+71YesNoNoNoYesNoNoNoNoNoNoNoNoNoUrbanE288AorticKermanMaleB+31NoNoNoNoNoNoYesNoNoNoNoNoNoUrbanE254MitralTehranMaleA+62NoNoNoYesNoNoNoNoNoNoYesNoNoUrbanE453AorticGilanMaleB+42NoNoNoNoNoNoNoNoNoNoNoNoNoUrbanBartonella spp.E251AorticKarajFemaleO+31YesNoNoNoYesNoNoNoNoYesNoNoNoNoUrbanE469Aortic & TricuspidTehranMaleA+64NoYesNoYesNoNoNoNoNoNoNoNoNoUrbanE419MitralTehranMaleO+43YesNoNoYesNoNoNoNoNoNoNoNoNoUrbanE313AorticTehranMaleB+63NoYesYesYesNoYesNoNoNoNoNoNoNoUrbanE465MitralTehranMaleO+31YesNoNoYesNoNoYesYesNoNoNoNoYesUrbanE270Mitral & AorticTehranMaleA+56NoNoNoYesNoNoNoNoNoNoNoNoNoUrbanE268MitralTehranMaleO-78YesNoNoNoNoNoNoNoNoNoNoNoNoNoUrbanE395AorticGolestanMaleA+34YesNoNoYesNoNoYesYesNoNoNoNoNoUrbanE394MitralLorestanMaleA+66YesNoYesYesYesNoNoNoNoNoNoNoNoYesUrbanE458MitralGilanMaleB+67NoNoYesNoYesNoNoNoNoNoNoNoNoUrbanE309PulmonaryQomFemaleO+22NoNoNoNoNoNoYesYesYesNoNoNoNoUrbanE254MitralTehranMaleA+62NoNoNoYesNoNoNoNoNoNoYesNoNoUrbanE240MitralTehranMaleB-31NoNoNoNoNoNoYesYesYesNoNoNoNoUrban Clinical characteristics of patients infected by Coxiella burnetii and Bartonella spp. Detection and species identification of Bartonella spp. Bartonella spp. were detected in 13 patients (5.6%). Six positive samples were obtained from Shahid Rajaee Heart Center and seven from Tehran Heart Center. The majority of affected patients were male (n = 10), with a mean age of 49 years. Mitral valve involvement was more frequent (53.34%); however, this association did not reach statistical significance (OR: 1.88; 95% CI: 0.65–5.3; P = 0.2). Most cases were from Tehran province, and three patients (23.1%) died (Table 5). Sequencing analysis confirmed Bartonella quintana in one case (the isolate E270b). The corresponding 16S rRNA gene sequence was deposited in the NCBI GenBank database under accession number PX675817 (https://www.ncbi.nlm.nih.gov/nuccore/PX675817). Fig. 1a presents the phylogenetic analysis of Bartonella spp., demonstrating that isolate E270b clusters within the B. quintana clade.Fig. 1(a): Phylogenetic tree based on 16S rRNA gene sequences of Bartonella spp., showing the relationship between reference strains and the study isolate E270b, which clusters within the Bartonella quintana lineage. (b): Venn diagram illustrating single and co-infections with Coxiella burnetii, Brucella spp., Bartonella spp., and Tropheryma whipplei detected by molecular analysis of heart valve tissues from patients with infective endocarditis. A: Bartonella; B: Coxiella burnetii; C: Brucella; D: Tropheryma whipplei. (a): Phylogenetic tree based on 16S rRNA gene sequences of Bartonella spp., showing the relationship between reference strains and the study isolate E270b, which clusters within the Bartonella quintana lineage. (b): Venn diagram illustrating single and co-infections with Coxiella burnetii, Brucella spp., Bartonella spp., and Tropheryma whipplei detected by molecular analysis of heart valve tissues from patients with infective endocarditis. A: Bartonella; B: Coxiella burnetii; C: Brucella; D: Tropheryma whipplei. Detection and species identification of Brucella spp. Brucella spp. DNA was detected in 20 patients (8.6%). Of these, 11 samples were from Shahid Rajaee Heart Center and five from Tehran Heart Center. Positive cases included 11 males and nine females, with a mean age of 45 years. The aortic valve (55%) was the most frequently involved one; however, this association did not reach statistical significance (OR: 1.9; 95% CI: 0.77–4.8; P = 0.15). Most patients originated from Tehran and Qazvin provinces, and four patients (20.0%) died (Table 6).Table 6Clinical characteristics of patients infected with Brucella spp. and Trophryma whipplei.Table 6Brucella sppPatients IDValveProvinceGenderBlood GroupAgeDeathSmokingDiabeticHigh Blood PressureDyspneaChest painEdemaFeverChillsFatigueWeight lossPalpitationSweatingCoughLocationE331AorticTehranMaleO+31NoNoNoYesNoNoNoNoYesNoNoNoNoUrbanE411AorticKarajFemaleAB+52NoNoYesYesNoNoYesNoNoNoYesNoNoUrbanE324MitralTehranFemaleB+71NoNoNoNoNoNoYesYesNoNoNoNoNoUrbanE415PericardiumTehranFemaleAB+50NoNoNoYesNoNoNoYesNoNoNoNoYesUrbanE266PulmonaryWest AzarbaijanMaleO+31NoNoNoYesNoNoYesNoNoNoNoNoNoVillageE259MitralTehranMaleAB+52NoNoNoYesNoNoYesYesNoNoNoYesNoUrbanE258AorticTehranFemaleO+4NoNoNoNoNoNoNoNoNoNoNoNoNoUrbanE261AorticKermanMaleO+46YesNoNoNoYesNoNoYesYesNoNoNoNoNoUrbanE256MitralKashanMaleO-22NoNoNoNoNoNoNoNoNoNoNoNoNoUrbanE414PericardiumTehranFemaleAB+69NoNoNoYesNoNoYesNoNoNoNoNoNoUrbanE410AorticQazvinFemaleB+63NoNoNoYesNoNoNoNoNoNoNoNoYesUrbanE326AorticMarkaziMaleB+51NoNoNoYesNoNoNoNoNoNoNoNoNoUrbanE284AorticGilanFemaleAB+29YesNoNoNoYesNoNoNoNoNoNoNoNoNoUrbanE262MitralQazvinFemaleA+37NoNoNoYesNoNoYesYesNoNoNoNoNoUrbanE252AorticTehranFemaleO+50YesNoNoNoYesNoNoNoNoNoYesNoNoNoUrbanE413PericardiumKermanshahMaleO+88NoNoNoYesNoNoNoNoNoNoNoNoYesUrbanE408AorticTehranMaleO+44NoNoNoNoYesNoNoNoNoNoNoYesNoUrbanE257AorticTehranMaleA+27NoNoNoNoYesNoNoNoNoYesNoNoNoUrbanE240MitralTehranMaleB-31NoNoNoNoNoNoYesYesYesNoNoNoNoUrbanE253AorticMazandaranMaleB+67YesNoNoNoYesNoNoYesYesNoNoNoYesNoUrbanTrophryma whippleiE331AorticTehranMaleO+31NoNoNoYesNoNoNoNoYesNoNoNoNoUrbanE460Mitral & AorticTehranFemaleA+41NoNoNoNoYesNoNoNoYesYesNoNoNoUrbanE355AorticMazandaranFemaleA+64NoNoYesYesNoNoNoNoNoNoNoNoNoUrbanE407AorticTehranMaleA-63NoYesYesYesYesNoNoNoNoNoNoNoNoUrbanE431AorticTehranMaleA+53YesNoNoNoYesNoNoNoNoNoNoNoNoUrbanE418PulmonaryGilanFemaleO+40NoNoNoYesNoNoNoNoNoNoNoNoNoUrbanE289AorticZanjanMaleO+70NoNoNoNoYesNoNoNoNoNoNoNoNoUrban Table 6Clinical characteristics of patients infected with Brucella spp. and Trophryma whipplei.Table 6Brucella sppPatients IDValveProvinceGenderBlood GroupAgeDeathSmokingDiabeticHigh Blood PressureDyspneaChest painEdemaFeverChillsFatigueWeight lossPalpitationSweatingCoughLocationE331AorticTehranMaleO+31NoNoNoYesNoNoNoNoYesNoNoNoNoUrbanE411AorticKarajFemaleAB+52NoNoYesYesNoNoYesNoNoNoYesNoNoUrbanE324MitralTehranFemaleB+71NoNoNoNoNoNoYesYesNoNoNoNoNoUrbanE415PericardiumTehranFemaleAB+50NoNoNoYesNoNoNoYesNoNoNoNoYesUrbanE266PulmonaryWest AzarbaijanMaleO+31NoNoNoYesNoNoYesNoNoNoNoNoNoVillageE259MitralTehranMaleAB+52NoNoNoYesNoNoYesYesNoNoNoYesNoUrbanE258AorticTehranFemaleO+4NoNoNoNoNoNoNoNoNoNoNoNoNoUrbanE261AorticKermanMaleO+46YesNoNoNoYesNoNoYesYesNoNoNoNoNoUrbanE256MitralKashanMaleO-22NoNoNoNoNoNoNoNoNoNoNoNoNoUrbanE414PericardiumTehranFemaleAB+69NoNoNoYesNoNoYesNoNoNoNoNoNoUrbanE410AorticQazvinFemaleB+63NoNoNoYesNoNoNoNoNoNoNoNoYesUrbanE326AorticMarkaziMaleB+51NoNoNoYesNoNoNoNoNoNoNoNoNoUrbanE284AorticGilanFemaleAB+29YesNoNoNoYesNoNoNoNoNoNoNoNoNoUrbanE262MitralQazvinFemaleA+37NoNoNoYesNoNoYesYesNoNoNoNoNoUrbanE252AorticTehranFemaleO+50YesNoNoNoYesNoNoNoNoNoYesNoNoNoUrbanE413PericardiumKermanshahMaleO+88NoNoNoYesNoNoNoNoNoNoNoNoYesUrbanE408AorticTehranMaleO+44NoNoNoNoYesNoNoNoNoNoNoYesNoUrbanE257AorticTehranMaleA+27NoNoNoNoYesNoNoNoNoYesNoNoNoUrbanE240MitralTehranMaleB-31NoNoNoNoNoNoYesYesYesNoNoNoNoUrbanE253AorticMazandaranMaleB+67YesNoNoNoYesNoNoYesYesNoNoNoYesNoUrbanTrophryma whippleiE331AorticTehranMaleO+31NoNoNoYesNoNoNoNoYesNoNoNoNoUrbanE460Mitral & AorticTehranFemaleA+41NoNoNoNoYesNoNoNoYesYesNoNoNoUrbanE355AorticMazandaranFemaleA+64NoNoYesYesNoNoNoNoNoNoNoNoNoUrbanE407AorticTehranMaleA-63NoYesYesYesYesNoNoNoNoNoNoNoNoUrbanE431AorticTehranMaleA+53YesNoNoNoYesNoNoNoNoNoNoNoNoUrbanE418PulmonaryGilanFemaleO+40NoNoNoYesNoNoNoNoNoNoNoNoNoUrbanE289AorticZanjanMaleO+70NoNoNoNoYesNoNoNoNoNoNoNoNoUrban Clinical characteristics of patients infected with Brucella spp. and Trophryma whipplei. Species-level identification revealed B. melitensis in eight samples and B. abortus in one sample. No samples tested positive for B. canis or B. suis. Detection of Tropheryma whipplei Tropheryma whipplei was detected in seven patients (3.0%), including four males and three females, with a mean age of 51 years. The aortic valve (75%) was the predominant site of infection (OR:4.7; 95% CI: 1–24; P = 0.05). Most positive cases were from Tehran province, and no deaths were reported among patients with T. whipplei–associated infective endocarditis (Table 6). Comparative analysis of detected pathogens Among the investigated pathogens, Brucella spp. showed the highest molecular frequency (8.6%), followed by C. burnetii (6.9%), Bartonella spp. (5.6%), and T. whipplei (3.0%). Male predominance was observed in all groups. Aortic valve involvement was most frequent in C. burnetii, Brucella spp., and T. whipplei infections, whereas mitral valve involvement predominated in Bartonella spp. cases. Mortality was observed in patients with C. burnetii, Brucella spp., and Bartonella spp., while no deaths occurred among T. whipplei–positive patients. Most positive cases across all pathogen groups originated from Tehran province. Dyspnea was identified as a significant risk factor across the analyzed pathogens, showing statistically significant associations with C. burnetii (OR: 3.2; 95% CI: 1–9.7; P = 0.02), Bartonella (OR: 3; 95% CI: 0.98–11; P = 0.04) and, Brucella (OR: 3.5; 95% CI: 1.3–9.6; P = 0.009). In addition, sweating (OR: 6; 95% CI: 1.4–26; P = 0.03) and fever (OR: 5.3, 95% CI: 2–14; P-value: 0.001) were significantly associated with Brucella infection (Table 4). As illustrated in Fig. 1b, analysis of molecular findings demonstrated the presence of both single and co-infections involving C. burnetii, Brucella spp., Bartonella spp., and T. whipplei. In addition to single-pathogen detections, overlapping infections between two or more pathogens were observed, indicating polymicrobial involvement in a proportion of blood culture–negative infective endocarditis cases. Discussion Infective endocarditis (IE), particularly blood culture–negative infective endocarditis (BCN-IE), remains a major diagnostic and therapeutic challenge, often leading to delayed or inappropriate treatment. This difficulty is especially pronounced for slow-growing, fastidious, or intracellular pathogens that are not readily detected by conventional culture methods and may lack reliable serological markers. After prior antibiotic exposure, fastidious and unculturable bacteria represent the second most common cause of negative blood culture results [24]. Consequently, molecular diagnostic techniques have gained increasing importance in the etiological identification of BCN-IE, as emphasized by the modified Duke criteria and the European Society of Cardiology (ESC) guidelines, which highlight C. burnetii, Bartonella spp., Brucella spp., Legionella spp., and T. whipplei as key pathogens requiring nucleic acid–based detection [6,8]. In the present study, a substantial proportion of patients had negative blood (68.5%) and tissue cultures (53.4%), underscoring the limitations of conventional microbiological methods in this setting. The demographic and clinical characteristics of our cohort—predominance of male patients, mean age of approximately 47 years, and frequent involvement of the aortic valve—are consistent with previous studies from Iran and other regions [18]. As expected, among culture-positive cases, Streptococcus, Staphylococcus, and Enterococcus species were the most frequently isolated pathogens, reflecting the typical microbiological spectrum of culture-positive IE [25]. C. burnetii, the most common cause of BCN-IE worldwide, accounted for 6.9% of IE cases in this study. Diagnosis of Q fever endocarditis is often challenging because of nonspecific clinical manifestations, variable serological responses, and the frequent absence of typical valvular vegetations or inflammatory changes. These factors contribute to underdiagnosis and delayed initiation of appropriate therapy, which has been associated with increased mortality in PCR-positive patients who did not receive anti–Coxiella treatment [24]. An important finding of this study relates to antimicrobial treatment patterns. The most commonly prescribed antibiotics before and after surgery included vancomycin, cefepime, cefixime, gentamicin, ampicillin, and cloxacillin. According to ESC guidelines, these regimens primarily target staphylococcal, streptococcal, and enterococcal infections and are generally ineffective against fastidious intracellular pathogens. This observation suggests that empirical treatment strategies may inadequately cover atypical causes of IE, likely due to challenges in pathogen identification or underrecognition of their clinical relevance. In contrast, current ESC recommendations for BCN-IE advocate doxycycline combined with hydroxychloroquine for C. burnetii and T. whipplei, doxycycline plus gentamicin for Bartonella spp., and doxycycline in combination with cotrimoxazole or rifampin for Brucella spp. [26], highlighting the importance of accurate etiological diagnosis to guide targeted therapy. In our cohort, C. burnetii infection predominantly affected relatively young patients (mean age 44 years) from urban areas, particularly Tehran and Gilan, with preferential involvement of the aortic valve. Similar patterns have been reported in Iranian studies conducted between 2016 and 2020 [18,27], although prevalence estimates varied widely (8–33%), likely reflecting differences in diagnostic strategies and study populations. The younger age distribution and urban predominance observed in Iran may represent an early warning signal for the increasing importance of Q fever in urban environments and its potential transmission through multiple routes. In contrast, studies from South Korea and other regions have reported higher prevalence rates, often affecting older patient populations [24,28]. Brucella spp. were detected in 8.6% of IE patients and approximately 12% of BCN-IE cases, with a mean age of 45 years. Although Brucella endocarditis is rare, it is clinically significant as the leading cause of mortality associated with brucellosis [29]. The prevalence observed in this study is higher than that reported in several earlier Iranian investigations, in which few or no cases were identified [30,31], suggesting possible underdiagnosis in previous studies. Species-level analysis revealed a predominance of B. melitensis, consistent with epidemiological data indicating this species as the most prevalent and virulent in Iran and other endemic regions [32]. Given the endemicity of brucellosis in Iran and ongoing exposure risks, incorporation of molecular testing for Brucella spp. into routine evaluation of BCN-IE is warranted. Bartonella spp. accounted for 5.6% of IE cases in this study, with B. quintana confirmed by sequencing in one case. Bartonella endocarditis has been reported globally and is estimated to cause 15–20% of BCN-IE cases [10,33]. Although dyspnea, fever, and sweating are non-specific clinical manifestations, their observed association with C. burnetii and Brucella spp. infections may have practical implications in patients with blood culture-negative infective endocarditis. In cases where conventional blood cultures remain negative and serological findings are unavailable or inconclusive, these clinical features may raise suspicion for zoonotic pathogens and may support earlier consideration of targeted molecular testing, including PCR-based assays, for these pathogens. However, these symptoms should not be considered diagnostic on their own and must be interpreted alongside microbiological and clinical findings. In Iran, previous studies have documented B. quintana predominantly in urban provinces, particularly Tehran and Golestan [18]. The well-established association of B. quintana with poor socioeconomic conditions, overcrowding, and ectoparasite exposure has been described in multiple regions worldwide [10,33]. In our cohort, Bartonella-associated IE primarily affected patients younger than 50 years and showed a predilection for mitral valve involvement, findings consistent with reports from India and Western countries [33,34]. Phylogenetic clustering of isolate E270b within the B. quintana clade corroborates the PCR-based species identification and indicates the circulation of this clinically relevant pathogen among patients with infective endocarditis, underscoring the value of integrating molecular detection with phylogenetic analysis in culture-negative cases. Endocarditis caused by T. whipplei, a rare cardiac manifestation of Whipple's disease, remains particularly challenging to diagnose due to its nonspecific clinical presentation and the inability of conventional microbiological methods to detect the organism [25]. As conventional microbiological methods are unable to detect this microorganism, most cases are identified incidentally through PCR analysis of excised heart valve tissue [35]. Epidemiological data suggest a higher prevalence of the disease in Europe, particularly France, Switzerland and Germany, and sporadic reports from North America. T. whipplei has been identified in 1-2.6% of cases with mean age of 55 years and symptoms of loss weight and diarrhea. Colonization usually occurs in childhood, but the development of the disease depends on genetic and immunological factors, as shown in familial cases by a decrease in Th1 and Th17 responses, as well as the human major histocompatibility complex genes DRB1∗13 and DQB1∗06 [36]. In our study, T. whipplei was detected in 3.0% of IE patients, with a mean age of 51 years and predominant aortic valve involvement, findings comparable to reports from Europe and North America, where prevalence rates of 1–7% have been described [8,25,35]. Although the observed prevalence in Iran appears low, this may reflect underdiagnosis, limited routine testing, or true epidemiological differences. Given the chronic course, immune evasion mechanisms, and potential for systemic involvement, increased clinical awareness and molecular testing for T. whipplei are essential in patients with BCN-IE [36,37]. The identification of co-infections involving multiple fastidious and intracellular pathogens further emphasizes the complexity of blood culture–negative infective endocarditis. The observed overlap among C. burnetii, Brucella spp., Bartonella spp., and T. whipplei, suggests shared or overlapping exposure routes, such as zoonotic transmission and vector-borne spread, in endemic settings. From a clinical perspective, polymicrobial involvement may contribute to diagnostic delays and suboptimal empiric antimicrobial therapy when molecular testing is not routinely implemented. These findings support current guideline recommendations advocating broad molecular investigation of excised valve tissues and reinforce the need for heightened clinical suspicion of mixed infections in BCN-IE. The higher prevalence of these pathogens among younger individuals and urban residents may reflect changing patterns of zoonotic exposure. Possible explanations include indirect exposure through companion animals, consumption of unpasteurized dairy products, increasing mobility between rural and urban regions, and airborne dissemination of contaminated aerosols originating from livestock farms or slaughterhouses located near urban areas. Although these hypotheses cannot be directly evaluated in the present study, they warrant further investigation in future epidemiological studies. This study has several limitations that should be acknowledged. First, its cross-sectional design precludes causal inference and limits the ability to assess temporal relationships between infection and clinical outcomes. Second, molecular analyses were performed on formalin-fixed paraffin-embedded heart valve tissues obtained after surgical intervention, which may not fully represent the entire spectrum of infective endocarditis, particularly cases managed conservatively. Third, prior antimicrobial exposure in many patients may have influenced both culture results and molecular detection rates. In addition, although species-level identification was performed for Brucella spp. and Bartonella spp., sequencing was not available for all positive samples, potentially limiting comprehensive genotypic characterization. Finally, serological data were not systematically available for all patients, precluding direct comparison between molecular and serological diagnostic approaches. Despite these limitations, the relatively large sample size and multicenter design strengthen the validity of the findings. Furthermore, detailed epidemiological information regarding occupational exposure, animal contact, and consumption of unpasteurized dairy products was not consistently available in the medical records. Future prospective studies should systematically collect these data to enable a more comprehensive assessment of risk factors associated with zoonotic infective endocarditis. Conclusions This study demonstrates that major fastidious and intracellular pathogens, including C. burnetii, Bartonella spp., Brucella spp., and T. whipplei, play a clinically important role in blood culture–negative infective endocarditis in Iran. The identification of zoonotic and fastidious pathogens underscores the relevance of public health interventions, including food safety measures, livestock surveillance, and improved diagnostic awareness. The findings highlight the limitations of conventional diagnostic approaches and emphasize the critical value of molecular analysis of heart valve tissues for accurate etiological diagnosis. Integrating molecular methods into routine clinical practice can facilitate timely, pathogen-directed antimicrobial therapy, improve patient management, and reduce morbidity and mortality associated with infective endocarditis. CRediT authorship contribution statement Arezoo Dehghan: Writing – original draft, Methodology, Investigation, Formal analysis, Data curation. Mohammad Hossein Ahmadi: Writing – review & editing, Supervision, Project administration, Methodology, Data curation, Conceptualization. Saber Esmaeili: Writing – review & editing, Supervision, Methodology, Investigation. Mohammad Ali Boroumand: Writing – review & editing, Methodology, Investigation. Mahshid Hesami: Writing – review & editing, Methodology, Investigation. Ethics approval and consent to participate The study design was approved by the Ethics Committee of Shahed University (Approval ID: IR.SHAHED.REC.1403.075), and followed the statements of the Declaration of Helsinki. Data availability statement The original contributions presented in the study are included in the article/supplementary material; further inquiries can be directed to the corresponding authors. Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.